Jay E. Gold
Impact in
-
- Viral-associated cancers and disorders
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Co-authors
- Ralph Zalusky (8 shared papers)Howe Jung Ree (2 shared papers)Amjad Ali Khan (2 shared papers)Michael E. Osband (8 shared papers)Antonio Castella (4 shared papers)Stephen C. Malamud (4 shared papers)James A. Strauchen (1 shared paper)James P. Crowley (1 shared paper)
- Journals
- Cancer (6 papers)American Journal of Hematology (4 papers)Journal of Surgical Oncology (2 papers)European Journal of Cancer (1 paper)Journal of Immunotherapy (1 paper)
- Partner nations
- United States
In The Last Decade
Jay E. Gold
23 papers receiving 423 citations
Peers
Comparison fields: 5 of 50
- Oncology 232
- Pathology and Forensic Medicine 135
- Genetics 49
- Neurology 69
- Hematology 52
Countries citing papers authored by Jay E. Gold
This map shows the geographic impact of Jay E. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay E. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay E. Gold more than expected).
Fields of papers citing papers by Jay E. Gold
This network shows the impact of papers produced by Jay E. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay E. Gold. The network helps show where Jay E. Gold may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay E. Gold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 89 | |
| 2 | 1992 | 47 | |
| 3 | 1990 | 45 | |
| 4 | 1990 | 39 | |
| 5 | 1991 | 36 | |
| 6 | 1987 | 30 | |
| 7 | 1993 | 29 | |
| 8 | 1988 | 24 | |
| 9 | 1995 | 16 | |
| 10 | 1993 | 15 | |
| 11 | 1989 | 14 | |
| 12 | 1989 | 14 | |
| 13 | 1995 | 13 | |
| 14 | 1991 | 10 | |
| 15 | 1995 | 10 | |
| 16 | 1992 | 9 | |
| 17 | Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma. | 1978 | 8 |
| 18 | 1994 | 4 | |
| 19 | 1995 | 4 | |
| 20 | 1995 | 3 |
About Jay E. Gold
Jay E. Gold is a scholar working on Oncology, Genetics, Immunology, Hematology and Virology, having authored 23 papers that have together received 463 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Viral-associated cancers and disorders (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Oncology (232 citations), Pathology and Forensic Medicine (135 citations), Genetics (49 citations), Neurology (69 citations) and Hematology (52 citations). Jay E. Gold has collaborated with scholars based in United States. Frequent co-authors include Ralph Zalusky, Howe Jung Ree, Amjad Ali Khan, Michael E. Osband, Antonio Castella, Stephen C. Malamud, James A. Strauchen, James P. Crowley, John M. Cosgrove and Scott D. Gold. Their work appears in journals such as Cancer, American Journal of Hematology, Journal of Surgical Oncology, European Journal of Cancer and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.